|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.99 CNY | -0.76% |
|
-6.62% | -0.97% |
| 01-22 | Hengrui Pharmaceuticals' Subsidiaries Get Nod to Trial Two Tumor Drugs | MT |
| 01-21 | Hengrui Pharmaceuticals' Unit Gets Nod to Trial Diabetes Drugs | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 56.71B | |||||
| 974B | |||||
| 526B | |||||
| 385B | |||||
| 376B | |||||
| 284B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition